Amyloid-Peptide Vaccinations Reduce β-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer’s Transgenic Mice
- 30 November 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 175 (5), 2099-2110
- https://doi.org/10.2353/ajpath.2009.090159
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer DiseasePublished by Elsevier BV ,2009
- Mannan-Abeta28conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) miceJournal of Neuroinflammation, 2008
- A limited role for microglia in antibody mediated plaque clearance in APP miceNeurobiology of Disease, 2007
- Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomersMolecular Neurodegeneration, 2007
- The influence of visual ability on learning and memory performance in 13 strains of miceLearning & Memory, 2007
- Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloidNeuroscience, 2007
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995
- Optic-Nerve Degeneration in Alzheimer's DiseaseThe New England Journal of Medicine, 1986